Cash Flow Statement
Growth Metrics

Xtant Medical Holdings (XTNT) Finished Goods (2019 - 2025)

Xtant Medical Holdings has reported Finished Goods over the past 7 years, most recently at $19.8 million for Q4 2025.

  • Quarterly Finished Goods fell 32.28% to $19.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.8 million through Dec 2025, down 32.28% year-over-year, with the annual reading at $19.8 million for FY2025, 32.28% down from the prior year.
  • Finished Goods was $19.8 million for Q4 2025 at Xtant Medical Holdings, down from $30.6 million in the prior quarter.
  • Over five years, Finished Goods peaked at $31.9 million in Q3 2024 and troughed at $10.6 million in Q2 2022.
  • The 5-year median for Finished Goods is $18.1 million (2021), against an average of $20.6 million.
  • Year-over-year, Finished Goods surged 158.62% in 2024 and then crashed 32.28% in 2025.
  • A 5-year view of Finished Goods shows it stood at $11.8 million in 2021, then fell by 7.67% to $10.9 million in 2022, then skyrocketed by 158.35% to $28.1 million in 2023, then rose by 4.08% to $29.2 million in 2024, then tumbled by 32.28% to $19.8 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Finished Goods are $19.8 million (Q4 2025), $30.6 million (Q3 2025), and $31.2 million (Q2 2025).